Short Interest in ASP Isotopes Inc. (NASDAQ:ASPI) Grows By 52.1%

ASP Isotopes Inc. (NASDAQ:ASPI) was the target of a large increase in short interest in April. As of April 15th, there was short interest totalling 722,000 shares, an increase of 52.1% from the March 31st total of 474,600 shares. Approximately 3.2% of the company’s stock are sold short. Based on an average trading volume of 638,000 shares, the short-interest ratio is currently 1.1 days.

Analyst Upgrades and Downgrades

Separately, HC Wainwright lifted their target price on ASP Isotopes from $5.25 to $5.50 and gave the stock a “buy” rating in a research note on Wednesday, April 17th.

Insider Buying and Selling at ASP Isotopes

In related news, Director Robert John Andrew Ryan acquired 15,596 shares of the company’s stock in a transaction on Monday, January 29th. The shares were acquired at an average cost of $2.35 per share, for a total transaction of $36,650.60. Following the purchase, the director now owns 537,055 shares in the company, valued at $1,262,079.25. The acquisition was disclosed in a legal filing with the SEC, which is accessible through this link. Company insiders own 26.30% of the company’s stock.

Institutional Investors Weigh In On ASP Isotopes

A hedge fund recently bought a new stake in ASP Isotopes stock. HTLF Bank acquired a new stake in ASP Isotopes Inc. (NASDAQ:ASPI) during the fourth quarter, according to its most recent 13F filing with the SEC. The fund acquired 78,538 shares of the company’s stock, valued at approximately $141,000. HTLF Bank owned 0.16% of ASP Isotopes as of its most recent filing with the SEC. 16.80% of the stock is owned by institutional investors.

ASP Isotopes Stock Performance

Shares of NASDAQ ASPI traded up $0.06 during mid-day trading on Friday, reaching $3.44. 719,042 shares of the company’s stock were exchanged, compared to its average volume of 764,084. ASP Isotopes has a 52 week low of $0.28 and a 52 week high of $4.97. The firm has a 50-day moving average price of $3.71 and a two-hundred day moving average price of $2.49. The company has a current ratio of 1.85, a quick ratio of 1.85 and a debt-to-equity ratio of 0.01.

ASP Isotopes (NASDAQ:ASPI) last announced its quarterly earnings data on Wednesday, April 10th. The company reported ($0.09) earnings per share (EPS) for the quarter. The company had revenue of $0.43 million during the quarter. Equities research analysts anticipate that ASP Isotopes will post -0.11 earnings per share for the current year.

About ASP Isotopes

ASP Isotopes Inc, a development stage advanced materials company, focuses on the production, distribution, marketing, and sale of isotopes. It engages in the production and commercialization of Molybdenum-100, a non-radioactive isotope for the medical industry; Carbon-14; and Silicon-28. The company is also developing Quantum Enrichment technology to produce Ytterbium-176, Nickel-64, Lithium 6, Lithium7, and Uranium-235.